{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:04:12Z","timestamp":1791140652561,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004204","name":"Tongji University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Urology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ajur.2024.12.008","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T18:42:07Z","timestamp":1748112127000},"page":"11-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recurrence and prevention strategies for non-muscle-invasive bladder cancer: A comprehensive review"],"prefix":"10.1016","volume":"13","author":[{"given":"Wuhao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajur.2024.12.008_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajur.2024.12.008_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib3","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajur.2024.12.008_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bju.14047","article-title":"Impact of bladder cancer on health-related quality of life","volume":"121","author":"Smith","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2024.12.008_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer\u2014a clinical perspective","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.euo.2021.07.001","article-title":"Genome-wide meta-analysis identifies novel genes associated with recurrence and progression in non-muscle-invasive bladder cancer","volume":"5","author":"Galesloot","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/JU.0000000000000389","article-title":"American Urological Association nonmuscle invasive bladder cancer risk model validation\u2014should patient age be added to the risk model?","volume":"202","author":"Ravvaz","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.euo.2024.01.011","article-title":"Association of age with non-muscle-invasive bladder cancer: unearthing a biological basis for epidemiological disparities?","volume":"7","author":"Lobo","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.urology.2016.07.009","article-title":"Nonmuscular invasive urothelial carcinoma of the bladder in pediatric and young adult patients: age-related outcomes","volume":"99","author":"Caione","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2024.12.008_bib10","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.urology.2008.01.062","article-title":"Relationship between patient age and superficial transitional cell carcinoma characteristics","volume":"71","author":"Shi","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2024.12.008_bib11","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.eururo.2014.05.033","article-title":"The effect of age on the efficacy of maintenance Bacillus Calmette-Gu\u00e9rin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911","volume":"66","author":"Oddens","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jjco\/hyq241","article-title":"Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy?","volume":"41","author":"Yuge","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016223","article-title":"The impact of age on intravesical instillation of Bacille Calmette-Gu\u00e9rin treatment in patients with high-grade T1 bladder cancer","volume":"98","author":"Cal\u00f2","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.ajur.2024.12.008_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","article-title":"Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes","volume":"69","author":"Dobruch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2147\/CMAR.S181532","article-title":"Sex-related differences in urothelial cell carcinoma of the bladder in Germany","volume":"11","author":"Scheller","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ajur.2024.12.008_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00345-022-04116-x","article-title":"Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis","volume":"41","author":"Mori","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib18","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.3390\/cancers14246110","article-title":"Sex remains negative prognostic factor in contemporary cohort of high-risk non-muscle-invasive bladder cancer","volume":"14","author":"Bilski","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajur.2024.12.008_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2018.01.039","article-title":"Association between obesity and bladder cancer recurrence: a meta-analysis","volume":"480","author":"Lin","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajur.2024.12.008_bib20","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1007\/s00345-021-03755-w","article-title":"Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center","volume":"39","author":"Bree","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MOU.0000000000000092","article-title":"Sex steroids and gender differences in nonmuscle invasive bladder cancer","volume":"24","author":"Lucca","year":"2014","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib22","first-page":"1659","article-title":"Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?","volume":"24","author":"Ucpinar","year":"2019","journal-title":"J BUON"},{"key":"10.1016\/j.ajur.2024.12.008_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/bju.12448","article-title":"Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer","volume":"112","author":"Rieken","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2024.12.008_bib24","doi-asserted-by":"crossref","first-page":"20459","DOI":"10.1002\/cam4.6620","article-title":"Body mass index and waist circumference in relation to risk of recurrence and progression after non-muscle invasive bladder cancer","volume":"12","author":"Van Zutphen","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.ajur.2024.12.008_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.juro.2013.01.089","article-title":"Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder","volume":"190","author":"Kluth","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib26","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11255-015-1013-1","article-title":"Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer","volume":"47","author":"Xu","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ajur.2024.12.008_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229384","article-title":"No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression","volume":"15","author":"Evers","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ajur.2024.12.008_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00345-018-2397-1","article-title":"An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer","volume":"37","author":"Ferro","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1442-2042.2011.02845.x","article-title":"Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: a retrospective cohort study","volume":"18","author":"Hwang","year":"2011","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.699732","article-title":"Diabetes mellitus and obesity as risk factors for bladder cancer prognosis: a systematic review and meta-analysis","volume":"12","author":"Lu","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ajur.2024.12.008_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bju.15296","article-title":"The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu\u00e9rin","volume":"128","author":"Brooks","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2024.12.008_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820979247","article-title":"The prognostic value of body mass index in patients with urothelial carcinoma after surgery: a systematic review and meta-analysis","volume":"18","author":"Yang","year":"2020","journal-title":"Dose Response"},{"key":"10.1016\/j.ajur.2024.12.008_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib34","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1158\/0008-5472.CAN-09-1091","article-title":"Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer","volume":"69","author":"Stern","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajur.2024.12.008_bib35","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1096\/fj.12-227074","article-title":"Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions","volume":"27","author":"Besaratinia","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.ajur.2024.12.008_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/aje\/kwm167","article-title":"Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis","volume":"166","author":"Sanderson","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajur.2024.12.008_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2019.06.001","article-title":"Tobacco carcinogens and the methionine metabolism in human bladder cancer","volume":"782","author":"Wojtczyk-Miaskowska","year":"2019","journal-title":"Mutat Res Rev Mutat Res"},{"key":"10.1016\/j.ajur.2024.12.008_bib38","doi-asserted-by":"crossref","DOI":"10.5662\/wjm.v14.i2.91889","article-title":"Association between tobacco exposure and bladder cancer recurrence: a systematic review and meta-analysis","volume":"14","author":"Xiang","year":"2024","journal-title":"World J Methodol"},{"key":"10.1016\/j.ajur.2024.12.008_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MOU.0000000000000453","article-title":"Prevention of bladder cancer incidence and recurrence: tobacco use","volume":"28","author":"Soria","year":"2018","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib40","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1245\/s10434-015-5016-z","article-title":"Refraining from smoking for 15 years or more reduced the risk of tumor recurrence in non-muscle invasive bladder cancer patients","volume":"23","author":"Ogihara","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/JU.0000000000002449","article-title":"Association of biochemically verified post-diagnosis smoking and nonmuscle-invasive bladder cancer recurrence risk","volume":"207","author":"Furberg","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12885-022-09733-8","article-title":"Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor","volume":"22","author":"Jeong","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajur.2024.12.008_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/iju.13913","article-title":"Low-risk non-muscle-invasive bladder cancer: further prognostic stratification into the \u201cvery-low-risk\u201d group based on tumor size","volume":"26","author":"Lee","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/iju.13929","article-title":"Editorial comment to low-risk non-muscle-invasive bladder cancer: further prognostic stratification into the \u201cvery-low-risk\u201d group based on tumor size","volume":"26","author":"Zachos","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib45","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1007\/s13277-013-1547-8","article-title":"Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG","volume":"35","author":"Zachos","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajur.2024.12.008_bib46","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.urolonc.2020.06.034","article-title":"Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer\u2014examining the utility of classifying Ta bladder cancer based on size","volume":"38","author":"Tully","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jso.21642","article-title":"Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer","volume":"102","author":"Hugen","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib48","first-page":"524","article-title":"[Characteristics of lymph node metastasis in patients undergoing radical cystectomy for bladder cancer: a retrospective single-center study of 522 cases]","volume":"46","author":"Hao","year":"2014","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ajur.2024.12.008_bib49","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1464-410X.2012.11455.x","article-title":"Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy","volume":"111","author":"Tilki","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2024.12.008_bib50","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.euo.2018.08.018","article-title":"Tumor location may predict adverse pathology and survival following definitive treatment for bladder cancer: a national cohort study","volume":"2","author":"Weiner","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib51","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4103\/njcp.njcp_503_19","article-title":"Clinical and pathological factors predictive of bladder cancer recurrence in patients with upper tract primary TCC","volume":"24","author":"Yoldas","year":"2021","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.ajur.2024.12.008_bib52","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.urology.2011.11.070","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy","volume":"79","author":"Gondo","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2024.12.008_bib53","first-page":"3027","article-title":"Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy","volume":"22","author":"Rajwa","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ajur.2024.12.008_bib54","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2147\/CMAR.S289986","article-title":"Clinical value of postoperative neutrophil-to-lymphocyte ratio change as a detection marker of bladder cancer recurrence","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ajur.2024.12.008_bib55","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.urolonc.2014.06.010","article-title":"Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer","volume":"33","author":"Mano","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib56","first-page":"465","article-title":"Efficacy of different resections on non-muscle-invasive bladder cancer and analysis of the optimal surgical method","volume":"29","author":"Chen","year":"2015","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.ajur.2024.12.008_bib57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2147\/CMAR.S346764","article-title":"Clinical efficacy and quality of life assessment of partial cystectomy and plasmakinetic transurethral resection of tumor in bladder cancer patients","volume":"14","author":"Li","year":"2022","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ajur.2024.12.008_bib58","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/lsm.22565","article-title":"Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: a prospective, nonrandomized two-center trial with 36-month follow-up","volume":"48","author":"Chen","year":"2016","journal-title":"Laser Surg Med"},{"key":"10.1016\/j.ajur.2024.12.008_bib59","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3760\/cma.j.issn.0366-6999.20122705","article-title":"Holmium laser versus conventional transurethral resection of the bladder tumor","volume":"126","author":"Teng","year":"2013","journal-title":"Chin Med J"},{"key":"10.1016\/j.ajur.2024.12.008_bib60","first-page":"460","article-title":"Holmium laser in comparison with transurethral resection of the bladder tumor for non-muscle invasive bladder cancer: randomized clinical trial with 18-month follow-up","volume":"18","author":"Razzaghi","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.ajur.2024.12.008_bib61","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/end.2022.0328","article-title":"Standard transurethral resection vs. transurethral laser surgery for bladder cancer: a systematic review and meta-analysis comparing clinical outcomes and complications","volume":"37","author":"O'Sullivan","year":"2023","journal-title":"J Endourol"},{"key":"10.1016\/j.ajur.2024.12.008_bib62","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s11255-023-03752-5","article-title":"Safety, feasibility, and quality of thulium laser en-bloc resection for treatment of non-muscle invasive bladder cancer","volume":"55","author":"Assem","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ajur.2024.12.008_bib63","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00345-015-1568-6","article-title":"En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor","volume":"33","author":"Kramer","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.euros.2022.09.025","article-title":"Implementing a checklist for transurethral resection of bladder tumor to standardize outcome reporting: when high-quality resection could influence oncological outcomes","volume":"48","author":"Diana","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.ajur.2024.12.008_bib65","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s00345-023-04439-3","article-title":"A 10-year renaissance of en bloc resection of bladder tumors (ERBT): are we approaching the peak or is it back to the trough?","volume":"41","author":"Enikeev","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib66","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1007\/s00345-023-04629-z","article-title":"En bloc resection of bladder tumors (ERBT) revisited 12 years after reintroduction: too good to be further ignored","volume":"41","author":"Herrmann","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOU.0000000000000377","article-title":"Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype","volume":"27","author":"Herrmann","year":"2017","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/end.2020.0371","article-title":"Photodynamic diagnosis-assisted en bloc transurethral resection of bladder tumor for nonmuscle invasive bladder cancer: short-term oncologic and functional outcomes","volume":"35","author":"Miyake","year":"2021","journal-title":"J Endourol"},{"key":"10.1016\/j.ajur.2024.12.008_bib69","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u20142019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib70","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1464-410X.2012.10939.x","article-title":"Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome","volume":"110","author":"Turker","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2024.12.008_bib71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.eururo.2009.09.024","article-title":"Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort","volume":"57","author":"Fritsche","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib72","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bju.13146","article-title":"Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy","volume":"117","author":"Moschini","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2024.12.008_bib73","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2006.11.090","article-title":"Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer","volume":"177","author":"Raj","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib74","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1159\/000510137","article-title":"Is it safe to offer radical cystectomy to patients above 85 years of age? A long-term follow-up in a single-center institution","volume":"104","author":"Tamalunas","year":"2020","journal-title":"Urol Int"},{"key":"10.1016\/j.ajur.2024.12.008_bib75","doi-asserted-by":"crossref","first-page":"E486","DOI":"10.1111\/j.1464-410X.2012.11180.x","article-title":"Does patient age affect survival after radical cystectomy?","volume":"110","author":"Horovitz","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.ajur.2024.12.008_bib76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eururo.2006.11.004","article-title":"Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy","volume":"51","author":"Nielsen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib77","first-page":"110","article-title":"Vitamin E reduces superficial bladder cancer recurrence: a randomized controlled trial","volume":"3","author":"Mazdak","year":"2012","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.ajur.2024.12.008_bib78","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37494","article-title":"Selenium and vitamin E for prevention of non-muscle-invasive bladder cancer recurrence and progression: a randomized clinical trial","volume":"6","author":"Bryan","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajur.2024.12.008_bib79","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","article-title":"Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience","volume":"57","author":"Mariappan","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib80","first-page":"310","article-title":"A larger detrusor wall thickness increases the risk of non muscle invasive bladder cancer recurrence and progression: result from a multicenter observational study","volume":"70","author":"Cicione","year":"2018","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.ajur.2024.12.008_bib81","article-title":"Areca nut chewing and an impaired estimated glomerular filtration rate as significant risk factors for non-muscle-invasive bladder cancer recurrence","volume":"6","author":"Cao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajur.2024.12.008_bib82","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/iju.13389","article-title":"Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer","volume":"24","author":"Kobatake","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib83","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/iju.13402","article-title":"Editorial comment to chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer","volume":"24","author":"Naselli","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib84","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.acuro.2021.11.008","article-title":"[Immediate post-operative intravesical instillation of a single dose chemotherapy is not superior to continuous saline irrigation]","volume":"46","author":"T\u00fcrkeri","year":"2022","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.ajur.2024.12.008_bib85","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00345-019-02628-7","article-title":"Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors","volume":"37","author":"Zhou","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib86","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s13304-023-01525-4","article-title":"The prognosis and safety of continuous saline bladder irrigation in patients after transurethral resection of bladder tumors: a systematic review and meta-analysis of comparative study","volume":"75","author":"Wang","year":"2023","journal-title":"Updates Surg"},{"key":"10.1016\/j.ajur.2024.12.008_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12894-018-0408-6","article-title":"Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical mitomycin-C","volume":"18","author":"Lenis","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib88","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/01.ju.0000168657.51551.49","article-title":"Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer","volume":"174","author":"Brocks","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib89","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-5347(17)36198-0","volume":"149","author":"Oosterlinck","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib90","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eururo.2013.06.009","article-title":"Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review","volume":"64","author":"Perlis","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib91","doi-asserted-by":"crossref","first-page":"477","DOI":"10.6004\/jnccn.2013.0060","article-title":"Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"11","author":"Abern","year":"2013","journal-title":"Natl Compr Canc Netw"},{"key":"10.1016\/j.ajur.2024.12.008_bib92","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib93","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5455\/medarh.2022.76.198-201","article-title":"Comparison between intravesical chemotherapy epirubicin and mitomycin-C after TURB vs. TURB alone with recurrence rate of non-muscle invasive bladder cancer: meta-analysis","volume":"76","author":"Daryanto","year":"2022","journal-title":"Med Arch"},{"key":"10.1016\/j.ajur.2024.12.008_bib94","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00345-018-2196-8","article-title":"Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation","volume":"36","author":"Tanimoto","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib95","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.eururo.2008.01.015","article-title":"The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials","volume":"53","author":"Sylvester","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib96","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/21681805.2021.1938664","article-title":"Adverse events of hyperthermic intravesical chemotherapy for non-muscle invasive bladder cancer patients","volume":"55","author":"Thomsen","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib97","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/BLC-180191","article-title":"Hyperthermic intravesical chemotherapy for BCG unresponsive non-muscle invasive bladder cancer patients","volume":"4","author":"De Jong","year":"2018","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.ajur.2024.12.008_bib98","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2022.2129103","article-title":"Development and investigation of a novel device with gemcitabine for hyperthermic intravesical chemotherapy","volume":"40","author":"Jing","year":"2023","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ajur.2024.12.008_bib99","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11255-023-03849-x","article-title":"Comparison of hyperthermic intravesical chemotherapy and Bacillus Calmette-Gu\u00e9rin therapy in high-risk non-muscle invasive bladder cancer: a matched-pair analysis","volume":"56","author":"Pazir","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ajur.2024.12.008_bib100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fonc.2020.00029","article-title":"Thermal intravesical chemotherapy reduce recurrence rate for non-muscle invasive bladder cancer patients: a meta-analysis","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib101","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00432-019-02900-8","article-title":"Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer","volume":"145","author":"Lian","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib102","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajur.2024.12.008_bib103","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eururo.2024.09.012","article-title":"FGFR inhibition in urothelial carcinoma","volume":"87","author":"Li","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib104","doi-asserted-by":"crossref","first-page":"21944","DOI":"10.1002\/cam4.6768","article-title":"Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer","volume":"12","author":"Hannouneh","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.ajur.2024.12.008_bib105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(20)30540-4","article-title":"Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial","volume":"22","author":"Boorjian","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib106","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/JU.0000000000003195","article-title":"Safety, tolerability, and preliminary efficacy of TAR-200 in patients with muscle-invasive bladder cancer who refused or were unfit for curative-intent therapy: a phase 1 study","volume":"209","author":"Tyson","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib107","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2023.01.017","article-title":"A phase 1 trial of durvalumab in combination with Bacillus Calmette-Gu\u00e9rin (BCG) or external beam radiation therapy in patients with BCG-unresponsive non-muscle-invasive bladder cancer: the Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study","volume":"83","author":"Hahn","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib108","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.eururo.2023.08.004","article-title":"Phase 2 trial of atezolizumab in Bacillus Calmette-Gu\u00e9rin-unresponsive high-risk non-muscle-invasive bladder cancer: SWOG S1605","volume":"84","author":"Black","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib109","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200167","article-title":"IL-15 superagonist NAI in BCG-unresponsive non-muscle-invasive bladder cancer","volume":"2","author":"Chamie","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ajur.2024.12.008_bib110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.euo.2024.03.008","article-title":"Radiotherapy combined with a radiosensitizer for Bacillus Calmette-Gu\u00e9rin-unresponsive non-muscle-invasive carcinoma in situ bladder cancer: an open-label, single-arm, multicenter, phase 2 European Organisation for Research and Treatment of Cancer trial","volume":"7","author":"Achard","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib111","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.euf.2023.06.006","article-title":"Background and update for ECOG-ACRIN EA8212: a randomized phase 3 trial of intravesical Bacillus Calmette-Gu\u00e9rin (BCG) versus intravesical docetaxel and gemcitabine treatment in BCG-na\u00efve high-grade non-muscle-invasive bladder cancer (BRIDGE)","volume":"9","author":"Kates","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.ajur.2024.12.008_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.900496","article-title":"ERH gene and its role in cancer cells","volume":"12","author":"Pang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144475","article-title":"Comprehensive gene expression analysis after ERH gene knockdown in human bladder cancer T24 cell lines","volume":"738","author":"Pang","year":"2020","journal-title":"Gene (Amst)"},{"key":"10.1016\/j.ajur.2024.12.008_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.871687","article-title":"ERH interacts with EIF2\u03b1 and regulates the EIF2\u03b1\/ATF4\/CHOP pathway in bladder cancer cells","volume":"12","author":"Pang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajur.2024.12.008_bib115","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/1574892819666230908110107","article-title":"Comprehensive genomic analysis of puerarin in inhibiting bladderurothelial carcinoma cell proliferation and migration","volume":"19","author":"Ma","year":"2024","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.ajur.2024.12.008_bib116","doi-asserted-by":"crossref","first-page":"8440","DOI":"10.1038\/s41598-024-58809-x","article-title":"Optimal timing for the first cystoscopic follow-up using time-to-treatment initiation analysis of oncologic outcomes in primary non-muscle invasive bladder cancer","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajur.2024.12.008_bib117","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2012.05.008","article-title":"Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature","volume":"62","author":"Soukup","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib118","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","article-title":"Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Grossman","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib119","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.eururo.2012.01.018","article-title":"A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence","volume":"61","author":"Naselli","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib120","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1177\/147323001103900623","article-title":"Detection of bladder cancer recurrence with real-time three-dimensional ultrasonography-based virtual cystoscopy","volume":"39","author":"Gulsen","year":"2011","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ajur.2024.12.008_bib121","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2217\/bmm.15.120","article-title":"FGFR3 and cyclin D3 as urine biomarkers of bladder cancer recurrence","volume":"10","author":"Blanca","year":"2016","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.ajur.2024.12.008_bib122","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/973406","article-title":"Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer","volume":"2014","author":"Todenh\u00f6fer","year":"2014","journal-title":"Dis Markers"},{"key":"10.1016\/j.ajur.2024.12.008_bib123","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/cncy.21650","article-title":"Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion","volume":"124","author":"Chen","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.ajur.2024.12.008_bib124","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1158\/1078-0432.CCR-08-1103","article-title":"Allelic imbalance analysis using a single-nucleotide polymorphism microarray for the detection of bladder cancer recurrence","volume":"14","author":"Coenen","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajur.2024.12.008_bib125","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.18632\/oncotarget.7358","article-title":"Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence","volume":"7","author":"Izumi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajur.2024.12.008_bib126","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2013.06.010","article-title":"Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature","volume":"65","author":"Crivelli","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib127","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.eururo.2012.08.025","article-title":"Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer","volume":"63","author":"Rink","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2024.12.008_bib128","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.juro.2010.06.140","article-title":"Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists","volume":"184","author":"Bjurlin","year":"2010","journal-title":"J Urol"}],"container-title":["Asian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388225000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388225000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:50:21Z","timestamp":1778860221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214388225000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":128,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2214388225000529"],"URL":"https:\/\/doi.org\/10.1016\/j.ajur.2024.12.008","relation":{},"ISSN":["2214-3882"],"issn-type":[{"value":"2214-3882","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence and prevention strategies for non-muscle-invasive bladder cancer: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajur.2024.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Editorial Office of Asian Journal of Urology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}